Bayesian cost‐effectiveness analysis from clinical trial data

A key tool for assessing the relative cost-effectiveness of two treatments in health economics is the incremental C/E acceptability curve. We present Bayesian computations for this curve in the case where data on both costs and efficacy are available from a clinical trial. Analysis is given under various formulations of prior information. A case study is analysed in which reasonable prior information is shown to strengthen substantially the posterior inference, leading to a more conclusive assessment of cost-effectiveness. Calculations can be performed using readily available Bayesian software.

[1]  M Johannesson,et al.  A Note on Confidence Intervals in Cost-Effectiveness Analysis , 1998, International Journal of Technology Assessment in Health Care.

[2]  A H Briggs,et al.  A Bayesian approach to stochastic cost-effectiveness analysis. , 1999, Health economics.

[3]  A A Stinnett,et al.  Net Health Benefits , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[4]  David B. Dunson,et al.  Bayesian Data Analysis , 2010 .

[5]  A R Willan,et al.  Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem. , 1996, Health economics.

[6]  A Briggs,et al.  Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. , 1998, Health economics.

[7]  A O'Hagan,et al.  A framework for cost-effectiveness analysis from clinical trial data. , 2001, Health economics.

[8]  David R. Jones,et al.  An introduction to bayesian methods in health technology assessment , 1999, BMJ.

[9]  R. Pauwels,et al.  A 1-year comparison of turbuhaler vs pressurized metered-dose inhaler in asthmatic patients. , 1996, Chest.

[10]  M Meisner,et al.  Statistical inference for cost-effectiveness ratios. , 1997, Health economics.

[11]  P. Wakker,et al.  Confidence intervals for cost/effectiveness ratios. , 1995, Health economics.

[12]  W C Black,et al.  The CE Plane , 1990, Medical decision making : an international journal of the Society for Medical Decision Making.

[13]  B. Liljas,et al.  Cost-effectiveness analysis of a dry powder inhaler (Turbuhaler) versus a pressurised metered dose inhaler in patients with asthma. , 1997, PharmacoEconomics.

[14]  M J Al,et al.  Costs, effects and C/E-ratios alongside a clinical trial. , 1994, Health economics.

[15]  A J Moskowitz,et al.  Bayesian estimation of cost-effectiveness ratios from clinical trials. , 1999, Health economics.